相关实验视频

Updated: Jun 14, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

在患有全身性红血性狼的患者中,免疫性血小板缩

Ziqiang Zheng^1,2, Jiali Liu², Mingzhu Yun^1,2

¹Dalian Medical University, Dalian, Liaoning, China.

Clinical rheumatology

|December 3, 2024

概括

系统性红斑狼 (SLE) 与免疫血小板缺血 (ITP) 需要个性化治疗. 识别生物标志物是预测患者反应和改善这种复杂疾病的结果的关键.

科学领域:

风湿病学和血液学风湿病学和血液学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

免疫性血小板缺血 (ITP) 经常使系统性红斑狼 (SLE) 复杂化.
在SLE-ITP中,不同的临床表现和治疗反应表明了复杂的潜在病理生理学.
预测治疗反应对于优化结果和最小化SLE-ITP患者不良事件至关重要.

研究的目的:

系统地审查SLE-ITP的致病性.
为SLE-ITP提供当前和新兴治疗策略的全面概述.
探索影响SLE-ITP治疗反应的关键生物标志物.

主要方法:

对SLE-ITP病原和治疗方法的系统文献综述.
分析常规疗法 (葡萄糖皮质类药物,免疫抑制剂,IVIG).
评估新兴疗法,包括TPO-RAs,B细胞和血细胞向治疗.

主要成果:

新兴的疗法,如TPO-RA和向药物,对SLE-ITP有很大的前景.
生物标志物对于预测治疗疗效和指导个性化护理至关重要.
随机对照试验 (RCT) 对于验证新型治疗方法至关重要.

结论:

了解SLE-ITP病原体是开发有效治疗的关键.
需要个性化医疗方法,以生物标志物为指导,用于SLE-ITP管理.
需要进一步的研究和RCT来确认新的SLE-ITP疗法的安全性和有效性.

关键词:

免疫性血小板减少症.血小板是血小板的组成部分.系统性红血性狼 (Systemic lupus erythematosusus) 是一种全身性狼.

更多相关视频

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

相关概念视频

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...